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Introduction
The current reorganisation of the National Health Service offers health authorities the opportunity to purchase the pattern of provision that best meets the needs of the populations they serve. The realisation of this potential should, however, be informed by evidence about appropriate levels of provision and priorities.' A lack of such evidence currently clouds decisions and will continue to do so in the near future. As a short term expedient this paper considers the practicalities of drawing on available evidence to inform choices about the balance of care and examines the value of a rapid method of deriving utility values to incorporate into cost effectiveness measures.
Rationale
Evidence about cost effectiveness is crucial to purchasing decisions.2 With such evidence the costs of treating extra patients by particular interventions can be related to the benefits and the total benefit available to patients thus maximised.3 One difficulty, however, is in measuring benefit in a comparable manner for different interventions. One method of measuring benefit which aims to solve this problem is that of using utility values, of which the quality adjusted life year (QALY) is one form. 34 The QAL Y Toolkits has been used as a source document for determining utility values. 6 Although the toolkit does not claim to have validated any of its methods, they have recently become more widely used.79 Three methods are recommended for determining utility values: collecting disability-distress data using a self completed questionnaire (observational studies); eliciting views from selected reference groups; and reprocessing data from published sources. 5 Observational studies of long term outcomes cannot be a speedy method of informing decisions. Eliciting views from selected reference groups is also inappropriate as no reference group holds all the relevant information; in particular, clinicians may value health states differently from patients7 and often have little knowledge of long term outcomes.
To inform purchasing decisions in the short term, therefore, the most appropriate method is to base utility values (QALYs) on reprocessed data from published studies which measured quality of life as assessed by the patient. This method has been used to consider medical care in end stage renal failure, upper limb joint replacement, surgery for scoliosis, and drug treatment for cystic fibrosis.'0 I selected six common interventions that might be suitable for reprocessing data because they have a circumscribed purpose, the therapeutic technique is stable, and data are likely to be available on outcome: prostatectomy for benign prostatic hypertrophy, cataract surgery, inguinal hernia repair, total joint replacement to treat osteoarthrosis of hip and knee, and varicose vein surgery.
Methods
The Rosser classification of illness states, or Rosser can be rearranged to give this formula; the actual formulae used were slightly more complex as failure did not always occur immediately following surgery):
QALY gain= The change in health status, or quality adjustment, was combined with the life expectancy of patients at the mean age of operation.' Mean age of operation, operative mortality rates, and operation failure rates were taken from published reports.
The benefit from treatment, in terms of QALY gain, depends on both the QALYs of those undergoing surgery and the QALYs of those receiving the best alternative treatment. When there was no comparable group receiving such a treatment I assumed that the patients' condition without surgery would'be the same as that experienced before surgery. I also assumed that the final postoperative report was applicable to all remaining years after surgery and that failed surgery and no surgery were equivalent in terms of quality of life.
The results obtained were discounted to allow for time preference-that is, the fact that people generally prefer a nominally equal benefit sooner rather than later. Discount rates of 6% and 0% were applied: 6% is the recommended Treasury discount rate for public sector projects, but the Department of Health applies a 0% discount rate. 4a Results and comment No quality of life data were found for inguinal hernia repair or varicose vein surgery. Data were found for the treatment of cataract'5 but were not sufficiently detailed after surgery to be converted to Rosser values.
PROSTATECTOMY FOR BENIGN PROSTATIC HYPERTROPHY
I found one North American study which considered quality of life after prostatectomy.'6 It was associated with a further study'7 in which quality adjusted life months'8 were formed. I obtained from the authors a copy of the questionnaire used in the study, from which it was possible to assess that relevance of the indices used in the study to the disability and distress dimensions of the Rosser index. An activity index contained information on activities around the house, outside the home, and during leisure time and correlated most closely with the disability dimension of the Rosser index. A combination of the symptom score, as a proxy for pain and embarrassment, and the general health index, which included information on feelings, worries and pain, correlated most closely with the distress dimension of the Rosser index. The transformation used is shown in the appendix ( Two studies were found which considered the quality oflife of patients undergoing joint replacement. Eftekhar's study of hip replacement dates from 1971 and used surgeons' assessment of quality of life.' Only 61% of patients were treated for osteoarthrosis. The second study provided quality of life data on patients with osteoarthrosis undergoing hip or knee replacement. 22 The follow up lasted six months, and the sample size was small. The data were generated in the United States.
Eftekhar's study assessed quality of life in terms of pain and function. These data were reprocessed respectively into the distress and disability dimensions of the Rosser index (see appendix, 
The average ages of patients undergoing hip replacement in the two studies were 66-4 years22 and 64-25 years (assuming that ages were distributed symmetrically in each age group)."3 I assumed that the typical age of hip replacement was 65, at which age life expectancy is 15 3 years (average for men and women).'4 For hip replacement I assumed an operative mortality of 0 4%25 and a failure rate of 1-5% per annum. 26 The average age for knee replacement was 68 5 years in the study by Liang et aP2; a further study of over 8000 cases in Sweden found an average age for knee replacement of 69 6 years. 27 I therefore assumed that the typical age for knee replacement was 70 years, with a life expectancy of 12 years.'4 A 2% failure rate was used. 27 In the absence of other information the operative mortality was assumed to be similar to that for hip replacement. Table II shows considerable differences in the reprocessed data obtained from the two studies.
VALIDATION EXERCISE
The results of the validation exercise are shown in table III. For each category, and in both dimensions, both the median and the modal choices were equivalent to the transformation used. In addition, disagreement was never by more than one category either side of the transformation used.
PROBLEMS ASSOCIATED WITH THE ORIGINAL DATA
The most obvious difficulties in this exercise were obtaining data on quality of life for many conditions. This problem has been found by other researchers.5 28 Most conditions have not been studied in this way, and this is particularly so for "low technology" treatments such as minor surgery. 7 Even when data are found and can be reclassified into QALYs, both the location and timing of the original studies may affect their usefulness. At the time of the original study technology now commonly used may not have been available, and there may have been changes in the criteria for operation, thus altering the type of patients being treated. Thus effectiveness of treatment as measured in the original study may not reflect effectiveness in the local population.
In all but one case the data used in this study were generated in the United States. For many conditions, including benign prostatic hypertrophy,2' more operations are carried out in the United States than in the United Kingdom, and therefore the average patient may not be the same. The "extra" patients treated in the United States may have less severe disease. Interestingly, the study of hip replacement in the United Kingdom3 showed a higher average QALY benefit than the United States study.22 There were, however, other differences between the studies.
The method of measuring patient outcomes might The study design of the original research may limit the data that can be reprocessed into QALYs. Data must be detailed enough to allow information to be extracted about the effects both of surgery and of no surgery. When quality of life is compared before and after treatment no information is provided about patients not receiving surgery. All the original studies used here were of the before and after design, so I made the assumption that patients' quality of life neither improved nor deteriorated without surgery. There is some evidence that this is so for patients with benign prostatic hypertrophy,'0 but other assumptions may be equally valid. The before and after study design may also limit information on differences in life expectancy between treated and untreated individuals. With all study designs there may be inadequate follow up.
PROBLEMS RELATED TO REPROCESSING OF DATA
Decision rules for reprocessing data are likely to depend on value judgments and assumptions. Decisions must be made about which dimensions of the original data set are closest to those in the new index. These decisions may be difficult to make, particularly when the connections between the original dimensions and those of the new index are not obvious. Specific points on the chosen dimensions must then be mapped on to specific points in the new index. No guidance is available about the best way of making these judgments; nor is there research which tests the reliability or validity of using data in this way. Although the validation exercise lent some validity to the way I had reprocessed the data, the D'Aubigne and Postel numbers were the most simple of the three measures transformed, and much more diversity would probably have been obtained with more complicated measures.
Further assumptions must be made when data on disability and distress are published in separate tables. Then it becomes impossible to determine both sets of values for particular individuals. Different assumptions about the distribution of patients across the dimensions of the Rosser index will then lead to different overall QALY results. As an example of a possible assumption Williams suggests that patients who are more disabled tend to be more depressed." Here I assumed that distress was distributed evenly among patients with different levels of disability. If this information is not published, however, there is no way of knowing which is the more plausible assumption.
Conclusion
The aim of this research was to test a "quick and dirty" method of obtaining utility values (QALYs) to use in informing purchasing decisions by district health authorities. The results show a number of difficulties in using the reprocessing method suggested in The QALY toolkit5-even for relatively straightforward interventions. While the problems are not necessarily insurmountable, the value of the QALY estimates obtained should not be overstated. The findings in the three interventions for which data could be reprocessed were insufficiently robust to guide policy.
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concentrations achieved and prevention of hot flushes.
Subjects, methods, and results Premenopausal women undergoing bilateral oophorectomy were randomly allocated either oestradiol patches (0-05 mg oestradiol/24 hours; n= 12) or oestradiol implants (50 mg crystalline oestradiol pellet; n= 16) administered seven days after surgery. Blood samples for measurement of oestradiol, follicle stimulating hormone, and luteinising hormone concentrations were taken preoperatively, six days postoperatively, and after two and four months of treatment. Hormone concentrations were measured by routine radioimmunoassay. Oestradiol concentrations
